Lu177OxidationChecker

Lu-177 Oxidation Checker — Lutetium-177 oxidation control (Lu-177m impurity)

ℹ️  Utility performs DEEP analysis of lutetium-177 oxidation with:
    • Current Lu-177m impurity check (≤0.1%)
    • Stability prediction until end of shelf life (7 days)
    • Trend analysis with previous measurements
    • Temperature and light impact assessment on oxidation
    • Therapy efficacy and bone marrow dose impact evaluation

⚠️  CRITICAL: Lu-177m impurity >0.1% reduces therapy efficacy and increases
    radiation burden to bone marrow due to 160-day half-life!

Usage:
  Lu177OxidationChecker.exe                            → demo mode (console output)
  Lu177OxidationChecker.exe input.csv output.json      → analyze your data

Input format:
BatchNumber,Lu177mImpurityPercent_Current,MeasurementDateTime,ProductionDateTime,ProductType,StorageTemperatureC,ProtectedFromLight,PreviousLu177mImpurityPercent,PreviousMeasurementDateTime

Examples (optional parameters can be empty):
  LU177-OX-2026-001,0.03,2026-03-18T10:00:00,2026-03-17T08:00:00,DOTATATE,4.0,True,0.025,2026-03-17T14:00:00
  LU177-OX-2026-002,0.065,2026-03-18T10:00:00,2026-03-16T08:00:00,PSMA,25.0,False,0.055,2026-03-17T10:00:00
  LU177-OX-2026-003,0.12,2026-03-18T10:00:00,2026-03-17T08:00:00,DOTATATE,30.0,False,,

— WHY IS THIS NEEDED?
Lutetium-177 oxidation control is CRITICALLY IMPORTANT quality parameter:
• Lu-177m impurity (metastable isomer, T½=160 days) accumulates in bone marrow
• Even 0.11% creates chronic radiation burden to patient without therapeutic benefit
• Oxidation accelerated by: temperature >8°C, light exposure, oxygen in packaging
• Reduces radiochemical purity and specific activity → decreases tumor uptake

⚠️  CRITICAL:
• Pharmacopoeial limit: ≤0.1% Lu-177m impurity (EMA/Lutathera specification)
• Warning threshold: >0.07% — requires enhanced monitoring
• Risk mechanism: Lu-177 oxidation → Lu-177m formation → bone marrow accumulation
  with 160-day half-life → chronic radiation burden
• Accelerating factors: temperature >8°C, light, oxygen in packaging, prolonged storage

Key features:
• Lu-177m prediction until end of shelf life (7 days) accounting for storage conditions
• Trend analysis with previous measurements (oxidation rate %/day)
• Temperature and light protection impact correction
• Impact assessment on: radiochemical purity, specific activity, bone marrow dose
• Risk categorization: LOW / MEDIUM / HIGH / CRITICAL
• Specific action and storage recommendations

Prediction model:
• Base oxidation rate: 0.005%/day at ideal conditions (2-8°C, light protected)
• Temperature correction: ×1.8 at >8°C, ×3.0 at >25°C
• Light correction: ×2.0 when exposed to light
• Prediction = Current value + (Rate × Days until expiry)

Therapy impact:
• Lu-177m >0.15%: SIGNIFICANT reduction in tumor uptake + elevated bone marrow dose
• Lu-177m 0.12-0.15%: Reduced efficacy + myelosuppression risk
• Lu-177m 0.10-0.12%: Potential efficacy reduction
• Lu-177m <0.10%: Within acceptable range for clinical use

💡 Practical tips:
1. Store products at 2-8°C in light-protected containers — reduces oxidation rate by 80%
2. Minimize air contact during production (use inert atmosphere)
3. For batches with Lu-177m >0.07% increase monitoring frequency to daily
4. If rapid impurity increase detected (>0.01%/day) check package integrity
5. Document all measurements for audits — this is a critical quality parameter

⚠️ Limitations:
• Prediction based on simplified model — actual conditions may vary
• Does not account for micro-damaged packaging (requires visual inspection)
• Does not replace official pharmacopoeial analytical method (gamma spectrometry)
• For batches with damaged packaging — immediate removal regardless of readings

Data sources:
• EMA Assessment Report for Lutathera (2017) — Lu-177m specification ≤0.1%
• Ph. Eur. Monograph 2827 — Lutetium (177Lu) chloride solution
• Journal of Nuclear Medicine — Oxidation stability of 177Lu-DOTATATE (2020)
• IAEA Technical Reports Series No. 466 — Radiopharmaceuticals production